Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, 900 Commonwealth Ave E, Boston, MA 02215, USA.
Circulation. 2011 Jun 21;123(24):2811-8. doi: 10.1161/CIRCULATIONAHA.110.009928. Epub 2011 May 31.
Very low levels of cardiac troponin T are associated with an increased risk of cardiovascular death in patients with stable chronic coronary disease. Whether high-sensitivity cardiac troponin T levels are associated with adverse cardiovascular outcomes in individuals without cardiovascular disease (CVD) has not been well studied.
Using 2 complementary study designs, we evaluated the relationship between baseline cardiac troponin and incident CVD events among diabetic and nondiabetic participants in the Women's Health Study (median follow-up, 12.3 years). All diabetic women with blood specimens were included in a cohort study (n=512 diabetic women, n=65 events), and nondiabetic women were sampled for inclusion in a case-cohort analysis (n=564 comprising the subcohort, n=479 events). High-sensitivity cardiac troponin T was detectable (≥ 0.003 μg/L) in 45.5% of diabetic women and 30.3% of nondiabetic women (P<0.0001). In models adjusted for traditional risk factors and hemoglobin A(1c), detectable high-sensitivity cardiac troponin T was associated with subsequent CVD (myocardial infarction, stroke, cardiovascular death) in diabetic women (adjusted hazard ratio, 1.79; 95% confidence interval, 1.04 to 3.07, P=0.036) but not nondiabetic women (adjusted hazard ratio, 1.13; 95% confidence interval, 0.82 to 1.55; P=0.46). Further adjustment for amino-terminal pro-B-type natriuretic peptide and estimated renal function did not substantially alter this relationship among diabetic women (hazard ratio, 1.76; 95% confidence interval, 1.00 to 3.08; P=0.0499), which appeared to be driven by a 3-fold increase in CVD death that was not observed in nondiabetic women.
Very low but detectable levels of cardiac troponin T are associated with total CVD and CVD death in women with diabetes mellitus. Among healthy nondiabetic women, detectable compared with undetectable troponin was not associated with CVD events.
极低水平的心脏肌钙蛋白 T 与稳定型慢性冠状动脉疾病患者心血管死亡风险增加相关。在没有心血管疾病 (CVD) 的个体中,高敏心脏肌钙蛋白 T 水平是否与不良心血管结局相关尚未得到充分研究。
我们使用 2 种互补的研究设计,评估了基线心脏肌钙蛋白与女性健康研究中糖尿病和非糖尿病参与者发生 CVD 事件的关系(中位随访时间为 12.3 年)。所有有血样的糖尿病女性均纳入队列研究(n=512 名糖尿病女性,n=65 例事件),非糖尿病女性则纳入病例对照分析的子队列(n=564 名,n=479 例事件)。45.5%的糖尿病女性和 30.3%的非糖尿病女性可检测到高敏心脏肌钙蛋白 T(≥0.003μg/L)(P<0.0001)。在调整传统危险因素和糖化血红蛋白 A1c 后,可检测到的高敏心脏肌钙蛋白 T 与糖尿病女性随后发生的 CVD(心肌梗死、卒中和心血管死亡)相关(调整后的危险比为 1.79;95%置信区间为 1.04 至 3.07,P=0.036),但与非糖尿病女性无关(调整后的危险比为 1.13;95%置信区间为 0.82 至 1.55;P=0.46)。进一步调整氨基末端 pro-B 型利钠肽和估计的肾功能并没有显著改变糖尿病女性的这种关系(危险比为 1.76;95%置信区间为 1.00 至 3.08;P=0.0499),这似乎是由于 CVD 死亡风险增加了 3 倍,而在非糖尿病女性中并未观察到这种情况。
在患有糖尿病的女性中,极低但可检测到的心脏肌钙蛋白 T 水平与总 CVD 和 CVD 死亡相关。在健康的非糖尿病女性中,与不可检测的肌钙蛋白相比,可检测到的肌钙蛋白与 CVD 事件无关。